TP
GILD icon

TritonPoint Partners’s Gilead Sciences GILD Stock Holding History

TritonPoint Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$794K Buy
6,288
+1,416
+29% +$187K 0.07% 171
2026
Q1 		$679K Sell
4,872
-88
-2% -$12.3K 0.25% 99
2025
Q4 		$609K Buy
+4,960
New +$603K 0.33% 84

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TritonPoint Partners's GILD Position: Q2 2026 in Review

TritonPoint Partners increased its Gilead Sciences (GILD) stake by 29% in Q2 2026, buying an estimated $187K and bringing the position to 6,288 shares worth $794K. The position accounts for 0.07% of the portfolio, ranked #171.

TritonPoint Partners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,273 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • TritonPoint Partners held 6,288 shares of Gilead Sciences worth $794K as of Q2 2026.
  • TritonPoint Partners bought 1,416 Gilead Sciences shares in Q2 2026, an estimated $187K.
  • Gilead Sciences made up 0.07% of TritonPoint Partners's portfolio in Q2 2026, its #171 holding.
  • TritonPoint Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,273 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on TritonPoint Partners's 13F filing for Q2 2026, filed 13 Aug 2026.